PKC-alpha modulation by miR-483-3p in platinum-resistant ovarian carcinoma cellsNoemi Arrighetti, Laura Gatti, Nives Carenini et al.|Toxicology and Applied Pharmacology|2016Cited by 48
FoxO-1 contributes to the efficacy of the combination of the XPO1 inhibitor selinexor and cisplatin in ovarian carcinoma preclinical modelsCristina Corno, Paola Perego, Simone Stucchi et al.|Biochemical Pharmacology|2017Cited by 44